These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 24020129)
1. Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy. Mizui T; Teramachi H; Tachi T; Tamura K; Shiga H; Komada N; Umeda M; Koda A; Aoyama S; Goto C; Tsuchiya T Pharmazie; 2013 Aug; 68(8):706-10. PubMed ID: 24020129 [TBL] [Abstract][Full Text] [Related]
2. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. Asha NJ; Tompkins D; Wilcox MH J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493 [TBL] [Abstract][Full Text] [Related]
5. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis. Friedman G Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686 [TBL] [Abstract][Full Text] [Related]
6. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Rohde CL; Bartolini V; Jones N Nutr Clin Pract; 2009; 24(1):33-40. PubMed ID: 19244146 [TBL] [Abstract][Full Text] [Related]
7. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Parkes GC; Sanderson JD; Whelan K Lancet Infect Dis; 2009 Apr; 9(4):237-44. PubMed ID: 19324296 [TBL] [Abstract][Full Text] [Related]
8. [Diarrhea associated with Clostridium difficile. One-year retrospective study at a tertiary hospital]. Barreiro PM; Pintor E; Rosario Burón M; Díaz B; Valverde J; de la Torre F Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):359-63. PubMed ID: 9835150 [TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. Kim YG; Graham DY; Jang BI J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089 [TBL] [Abstract][Full Text] [Related]